Synapse - Works

Results (4808)

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM)

Meeting Abstract

Holstein, S. A.; Owzar, K.; Richardson, P. G.; Jiang, C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Devine, S. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study

Meeting Abstract

Hodi, F. S.; Postow, M. A.; Chesney, J. A.; Pavlick, A. C.; Robert, C.; Grossmann, K. F.; McDermott, D. F.; Linette, G. P.; Meyer, N.; Giguere, J. K.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Multicenter prospective phase II trial of bevacizumab (bev) for progressive pancreatic neuroendocrine tumor (PNET)

Meeting Abstract

Hobday, T. J.; Yin, J.; Pettinger, A.; Strosberg, J. R.; Reidy, D. L.; Chen, H. X.; Erlichman, C.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma

Meeting Abstract

Ho, A. L.; Foster, N. R.; Meyers, J. P.; Vasudeva, S. D.; Katabi, N.; Antonescu, C. R.; Pfister, D. G.; Horvath, L. E.; Erlichman, C.; Schwartz, G. K.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay

Meeting Abstract

Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Adjuvant chemotherapy for residual disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)

Meeting Abstract

Harshman, L. C.; Werner, L.; Wong, Y. N.; Yu, E. Y.; Alva, A. S.; Crabb, S. J.; Powles, T.; Rosenberg, J. E.; Baniel, J.; Vaishampayan, U. N.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Hepatocellular carcinoma (HCC) and bone metastases (Mets)

Meeting Abstract

Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors

Meeting Abstract

Harding, J. J.; Telli, M. L.; Munster, P. N.; Le, M. H.; Molineaux, C.; Bennett, M. K.; Mittra, E.; Burris, H. A.; Clark, A. S.; Dunphy, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D. F.; Ernstoff, M.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A. R. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

CheckMate 214: A phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in patients with previously untreated metastatic renal cell carcinoma

Meeting Abstract

Hammers, H. J.; Plimack, E. R.; Sternberg, C.; McDermott, D. F.; Larkin, J. M. G.; Ravaud, A.; Rini, B. I.; Sharma, P.; Bhagavatheeswaran, P.; Gagnier, P.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save